The effect of melatonin on 7,12-dimethyl-benz[a]anthracene injury in comparison with vitamin E + selenium in mouse kidneys

Fundamental and Clinical Pharmacology

Volumn 20, Issue 4, 2006, Pages 359-364

  Ozturk, Feral ^a   Ozturk, I Cetin ^a   Batcioglu, Kadir ^b   Vardi, Nigar ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

7,12 dimethyl benz a anthracene; Antioxidative enzymes; Melatonin; Morphometric analysis; Selenium; Vitamin E

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; MELATONIN; SELENIUM;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; EXPOSURE; FEMALE; FUNCTIONAL MORPHOLOGY; HISTOLOGY; INJECTION; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MEDICAL EXAMINATION; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION;

ANIMALS; ANTIOXIDANTS; BENZ(A)ANTHRACENES; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; MELATONIN; MICE; NECROSIS; RANDOM ALLOCATION; SELENIUM; VITAMIN E;

EID: 33745831621     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2006.00419.x     Document Type: Article

References (31)

1. Cavalieri E.L., Rogan E.G. The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation. Pharmacol. Ther. (1992) 50 183-199.
2. Cotran R.S., Kumar V., Collins T. (Eds). Neoplasia, in: Robbins' pathologic basis of disease, 6th edn, WB Saunders, Philadelphia, 1999, p. 309.
3. Fischer P.W.F., Campbell J.S., Giroux A. Effects of low copper and high zinc intakes and related changes in Cu, Zn-superoxide dismutase activity on DMBA-induced mammary tumorigenesis. Biol. Trace Elem. Res. (1991) 30 65-79.
4. Cotran R.S., Kumar V., Collins T. (eds). Cellular pathology I: cell injury and cell death, in: Robbins' pathologic basis of disease, 6th edn, WB Saunders, Philadelphia, 1999, p. 12.
5. Clemens M.R. Free radicals in chemical carcinogenesis. Klin. Wochenschr. (1991) 69 1123-1134.
6. Karbownik M., Lewinski A., Reiter R.J. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int. J. Biochem. Cell. Biol. (2001) 33 735-753.
7. Rao A.R., Hussain S.P., Jannu L.N., Ramana M.V. Modulatory influences of tamoxifen, tocopherol, retinyl acetate, amino-glutethimide, ergocryptine and selenium on DMBA-induced initiation of mammary carcinogenesis in rats. Indian J. Exp. Biol. (1990) 28 409-416.
8. Burton G.W., Ingold K.U. Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function. Acc. Chem. Res. (1986) 19 194-201.
9. Kelly F.J. Use of antioxidants in the prevention and treatment of disease. J. Int. Fed. Clin. Chem. (1998) 10 21-23.
10. Horvath P.M., Ip C. Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. Cancer Res. (1983) 43 5335-5341.
11. Naziroglu M., Karaoglu A., Aksoy A.O. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology (2004) 195 221-230.
12. Beytut E., Erisir M., Aksakal M. Effects of additional vitamin E and selenium supply on antioxidative defence mechanisms in the kidney of rats treated with high doses of glucocorticoid. Cell Biochem. Funct. (2004) 22 59-65.
13. Tan D.X., Manchester L.C., Reiter R.J. et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. (2000) 29 1177-1185.
14. Reiter R.J., Tan D.X., Cabrera J. et al. The oxidant/antioxidant network: role of melatonin. Biol. Signals Recept. (1999) 8 56-63.
15. Andersen H.R., Nielsen J.B., Nielsen F., Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin. Chem. (1997) 43 562-568.
16. Batcioglu K., Ozturk C., Karagozler A., Karatas F. Comparison of the selenium level with GSH-Px activity in the liver of mice treated with 7,12 DMBA. Cell Biochem. Funct. (2002) 20 115-118.
17. El-Bayoumy K., Chae Y.H., Upadhyaya P., Meschter C., Cohen L.A., Reddy B.S. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)-selenocyanate. Cancer Res. (1992) 52 2402-2407.
18. Luck H. Catalase, in: Bergmeyer H.U. (Ed.), Methods of enzymatic analysis, 2nd edn. Academic Press, New York, 1963, pp. 885-888.
19. Lawrence R.A., Burk R.F. GSH-Px activity in rat liver. Biochem. Biophys. Res. Commun. (1976) 71 952-958.
20. Cao Y., Wang J., Henry-Tillman R., Klimberg V.S. Effect of 7,12-dimethyl-benz[a]anthracene (DMBA) on gut glutathione metabolism. J. Surg. Res. (2001) 100 135-140.
21. Batcioglu K., Karagozler A.A., Gene M., Celik S. Comparison of the chemopreventive potentials of melatonin and vitamin E plus selenium on 7,12-dimethylbenz[a]anthracene-induced inhibition of the mouse liver antioxidant enzymes. Eur. Cancer Prev. (2002) 11 57-61.
22. Batcioglu K., Karagozler A.A., Ozturk I.C. et al. Comparison of the chemopreventive effects of vitamin E plus selenium vs. melatonin in 7,12-dimethylbenz[a]anthracene-induced inhibition of the mouse brain damage. Cancer Detect. Prev. (2005) 29 54-58.
23. Cotran R.S., Kumar V., Collins T. The kidney, in: Cotran R.S., Kumar V., Collins T. (Eds), Robbins' pathologic basis of disease, 6th edn, WB Saunders, Philadelphia, 1999, p. 969.
24. Ogawa Y., Wan F., Toyosawa S., Ijuhin N. Induction of adenocarcinoma containing myoepithelial cells in rat submandibular gland by 7.12-dimethylbenz(a)anthracene. Virchows Arch. (2000) 437 314-324.
25. Montilla P., Tunez I., Munoz M.C., Lopez A., Soria J.V. Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Nefron (1997) 76 345-350.
26. Sahna E., Parlakpinar H., Ozturk F., Cigremis Y., Acet A. The protective effect of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol. Res. (2003) 31 188-193.
27. Anisimov V.N., Zabezhinski M.A., Popovich I.G. et al. Inhibitory effect of melatonin on 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro. Cancer Lett. (2000) 156 199-205.
28. Pablos M.I., Guerrero J.M., Ortiz G.G., Agapito M.T., Reiter R.J. Both melatonin and a putative nuclear melatonin receptor agonist CGP 52608 stimulate glutathione peroxidase and glutathione reductase activities in mouse brain in vivo. Neuroendocrinol. Lett. (1998) 18 49-50.
29. Rodriguez C., Mayo J.C., Sainz R.M. et al. Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. (2004) 36 1-9.
30. Reiter R.J., Tan D.X., Sainz R.M., Mayo J.C., Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. (2002) 54 1299-1321.
31. Avula C.P.R., Fernandes G. Effect of dietary vitamin E on apoptosis and proliferation of murine splenocytes. Nutr. Res. (2000) 20 225-236.